Since elevated levels of adiponectin and HDL-C are known to protect against atherosclerosis, we propose that the modulation of adiponectin and/or HDL-C by fetuin-A might be an important contributor in the pathogenesis of atherosclerosis and CVD in NAFLD. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.